{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:24:32Z","timestamp":1793903072257,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2024,5,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Knowledge about thrombocytopenia among patients with solid tumors is scarce. We examined the risk of thrombocytopenia among patients with solid tumors and its association with adverse outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Using Danish health registries, we identified all patients with incident solid tumors from 2015-2018 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200952,380) and a platelet count measurement within 2 weeks prior to or on their cancer diagnosis\u00a0date. The risk of thrombocytopenia was categorized as grades 0 (any platelet count\u2009\u00d7\u200910\n                      <jats:sup>9<\/jats:sup>\n                      \/L): &lt;150; 1: &lt;100; 2: &lt;75; 3: &lt;50; 4: &lt;25, and 5: &lt;10. To study the outcomes, each patient with thrombocytopenia was matched with up to five cancer patients without thrombocytopenia by age, sex, cancer type, and stage. Cox regression was used to compute hazard ratios (HRs) of bleeding, transfusion, or death, adjusting for confounding factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 1-year risk of thrombocytopenia was 23%, increasing to 30% at 4 years. This risk was higher in patients receiving chemotherapy (43% at 1 year and 49% at 4 years). Overall, patients with thrombocytopenia had higher 30-days rates of bleeding (HR\u2009=\u20091.72 [95% confidence interval, CI: 1.41\u20132.11]). Thrombocytopenia was also associated with an increased rate of transfusion, and death, but some of the risk estimates were imprecise.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The risk of thrombocytopenia was substantial among patients with solid tumors and associated with adverse outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-024-02630-w","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T09:02:18Z","timestamp":1709715738000},"page":"1485-1492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Risk and adverse clinical outcomes of thrombocytopenia among patients with solid tumors\u2014a Danish population-based cohort study"],"prefix":"10.1038","volume":"130","author":[{"given":"Kasper","family":"Adelborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Veres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erzs\u00e9bet","family":"Horv\u00e1th-Puh\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Clouser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-7040","authenticated-orcid":false,"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"2630_CR1","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/S0049-3848(14)50011-4","volume":"133","author":"HA Liebman","year":"2014","unstructured":"Liebman HA. Thrombocytopenia in cancer patients. Thromb Res. 2014;133:S63\u201369.","journal-title":"Thromb Res"},{"key":"2630_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/bjh.17172","volume":"192","author":"K Adelborg","year":"2021","unstructured":"Adelborg K, Larsen JB, Hvas AM. Disseminated intravascular coagulation: epidemiology, biomarkers, and management. Br J Haematol. 2021;192:803\u201318.","journal-title":"Br J Haematol"},{"key":"2630_CR3","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pi\u00f1eros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941\u201353.","journal-title":"Int J Cancer"},{"key":"2630_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5354-5","volume":"19","author":"D Weycker","year":"2019","unstructured":"Weycker D, Hatfield M, Grossman A, Hanau A, Lonshteyn A, Sharma A, et al. Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice. BMC Cancer. 2019;19:151.","journal-title":"BMC Cancer"},{"key":"2630_CR5","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.clinthera.2009.11.020","volume":"31","author":"Y Wu","year":"2009","unstructured":"Wu Y, Aravind S, Ranganathan G, Martin A, Nalysnyk L. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007. Clin Ther. 2009;31:2416\u201332.","journal-title":"Clin Ther"},{"key":"2630_CR6","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/ejh.13595","volume":"106","author":"JL Shaw","year":"2021","unstructured":"Shaw JL, Nielson CM, Park JK, Marongiu A, Soff GA. The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies. Eur J Haematol. 2021;106:662\u201372.","journal-title":"Eur J Haematol"},{"key":"2630_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1055\/s-0039-3402429","volume":"46","author":"JB Larsen","year":"2020","unstructured":"Larsen JB, Hojbjerg JA, Hvas AM. The role of platelets in cancer-related bleeding risk: a systematic review. Semin Thromb Hemost. 2020;46:328\u201341.","journal-title":"Semin Thromb Hemost"},{"key":"2630_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/CLEP.S179083","volume":"11","author":"M Schmidt","year":"2019","unstructured":"Schmidt M, Schmidt SAJ, Adelborg K, Sundb\u00f8ll J, Laugesen K, Ehrenstein V, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563\u201391.","journal-title":"Clin Epidemiol"},{"key":"2630_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2147\/CLEP.S314959","volume":"13","author":"K Laugesen","year":"2021","unstructured":"Laugesen K, Ludvigsson JF, Schmidt M, Gissler M, Valdimarsdottir UA, Lunde A, et al. Nordic health registry-based research: a review of health care systems and key registries. Clin Epidemiol. 2021;13:533\u201354.","journal-title":"Clin Epidemiol"},{"key":"2630_CR10","first-page":"535","volume":"44","author":"HH Storm","year":"1997","unstructured":"Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull. 1997;44:535\u20139.","journal-title":"Dan Med Bull"},{"key":"2630_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/CLEP.S245060","volume":"12","author":"JFH Arendt","year":"2020","unstructured":"Arendt JFH, Hansen AT, Ladefoged SA, S\u00f8rensen HT, Pedersen L, Adelborg K. Existing data sources in clinical epidemiology: laboratory information system databases in Denmark. Clin Epidemiol. 2020;12:469\u201375.","journal-title":"Clin Epidemiol"},{"key":"2630_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","volume":"7","author":"M Schmidt","year":"2015","unstructured":"Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, S\u00f8rensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449\u201390.","journal-title":"Clin Epidemiol"},{"key":"2630_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","volume":"29","author":"M Schmidt","year":"2014","unstructured":"Schmidt M, Pedersen L, S\u00f8rensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541\u20139.","journal-title":"Eur J Epidemiol"},{"key":"2630_CR14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/ije\/dyr213","volume":"41","author":"PK Andersen","year":"2012","unstructured":"Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol. 2012;41:861\u201370.","journal-title":"Int J Epidemiol"},{"key":"2630_CR15","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2147\/CLEP.S164456","volume":"10","author":"U Heide-J\u00f8rgensen","year":"2018","unstructured":"Heide-J\u00f8rgensen U, Adelborg K, Kahlert J, S\u00f8rensen HT, Pedersen L. Sampling strategies for selecting general population comparison cohorts. Clin Epidemiol. 2018;10:1325\u201337.","journal-title":"Clin Epidemiol"},{"key":"2630_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1182\/asheducation.V2012.1.191.3798260","volume":"1","author":"R Stasi","year":"2012","unstructured":"Stasi R. How to approach thrombocytopenia. Hematology Am Soc Hematol Educ Program. 2012;1:191\u20137.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2630_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1182\/asheducation-2016.1.251","volume":"1","author":"MP Lambert","year":"2016","unstructured":"Lambert MP. Platelets in liver and renal disease. Hematology Am Soc Hematol Educ Program. 2016;1:251\u20135.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2630_CR18","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO;2-2","volume":"33","author":"J Inagaki","year":"1974","unstructured":"Inagaki J, Rodriguez V, Bodey GP. Proceedings: causes of death in cancer patients. Cancer. 1974;33:568\u201373.","journal-title":"Cancer"},{"key":"2630_CR19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","volume":"5","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost. 2007;5:632\u20134.","journal-title":"J Thromb Haemost"},{"key":"2630_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.amjsurg.2018.06.019","volume":"217","author":"ZA AlRstum","year":"2019","unstructured":"AlRstum ZA, Huynh TT, Huang SY, Pisimisis GT. Risk of bleeding after ultrasound-guided jugular central venous catheter insertion in severely thrombocytopenic oncologic patients. Am J Surg. 2019;217:133\u20137.","journal-title":"Am J Surg"},{"key":"2630_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/bjh.12928","volume":"166","author":"LJ Estcourt","year":"2014","unstructured":"Estcourt LJ, Stanworth SJ, Harrison P, Powter G, McClure M, Murphy MF, et al. Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study. Br J Haematol. 2014;166:581\u201391.","journal-title":"Br J Haematol"},{"key":"2630_CR22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1365-2141.2004.05335.x","volume":"128","author":"EB Leinoe","year":"2005","unstructured":"Leinoe EB, Hoffmann MH, Kjaersgaard E, Nielsen JD, Bergmann OJ, Klausen TW, et al. Prediction of haemorrhage in the early stage of acute myeloid leukaemia by flow cytometric analysis of platelet function. Br J Haematol. 2005;128:526\u201332.","journal-title":"Br J Haematol"},{"key":"2630_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-017-0341-y","volume":"7","author":"L Russell","year":"2017","unstructured":"Russell L, Holst LB, Kjeldsen L, Stensballe J, Perner A. Risks of bleeding and thrombosis in intensive care unit patients with haematological malignancies. Ann Intensive Care. 2017;7:119.","journal-title":"Ann Intensive Care"},{"key":"2630_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1423-0410.2006.00785.x","volume":"91","author":"SJ Stanworth","year":"2006","unstructured":"Stanworth SJ, Dyer C, Casbard A, Murphy MF. Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding. Vox Sang. 2006;91:63\u201369.","journal-title":"Vox Sang"},{"key":"2630_CR25","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1182\/blood-2017-01-757930","volume":"130","author":"L Uhl","year":"2017","unstructured":"Uhl L, Assmann SF, Hamza TH, Harrison RW, Gernsheimer T, Slichter SJ. Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial. Blood. 2017;130:1247\u201358.","journal-title":"Blood"},{"key":"2630_CR26","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1200\/JCO.2001.19.4.1137","volume":"19","author":"LS Elting","year":"2001","unstructured":"Elting LS, Rubenstein EB, Martin CG, Kurtin D, Rodriguez S, Laiho E, et al. Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia. J Clin Oncol. 2001;19:1137\u201346.","journal-title":"J Clin Oncol"},{"key":"2630_CR27","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1002\/cncr.10603","volume":"94","author":"LS Elting","year":"2002","unstructured":"Elting LS, Martin CG, Kurtin DJ, Cantor SB, Rubenstein EB, Rodriguez S, et al. The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors. Cancer. 2002;94:3252\u201362.","journal-title":"Cancer"},{"key":"2630_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.thromres.2017.08.005","volume":"158","author":"R Patell","year":"2017","unstructured":"Patell R, Gutierrez A, Rybicki L, Khorana AA. Identifying predictors for bleeding in hospitalized cancer patients: a cohort study. Thromb Res. 2017;158:38\u201343.","journal-title":"Thromb Res"},{"key":"2630_CR29","first-page":"2971","volume":"24","author":"JA Ryu","year":"2016","unstructured":"Ryu JA, Lee D, Yang JH, Chung CR, Park CM, Suh GY, et al. Spontaneous intracranial haemorrhage in critically ill patients with malignancies. Support Care Cancer. 2016;24:2971\u20138.","journal-title":"Support Care Cancer"},{"key":"2630_CR30","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.7150\/jca.29606","volume":"10","author":"CC Huang","year":"2019","unstructured":"Huang CC, Chao PJ, Guo SS, Wang CJ, Luo HL, Su YL, et al. Developing a multivariable normal tissue complication probability model to predict late rectal bleeding following intensity-modulated radiation therapy. J Cancer. 2019;10:2588\u201393.","journal-title":"J Cancer"},{"key":"2630_CR31","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/j.1464-410X.2008.07780.x","volume":"102","author":"ST Tagawa","year":"2008","unstructured":"Tagawa ST, Dorff TB, Rochanda L, Ye W, Boyle S, Raghavan D, et al. Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy. BJU Int. 2008;102:1086\u201391.","journal-title":"BJU Int"},{"key":"2630_CR32","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.5754\/hge11090","volume":"58","author":"S Tanaka","year":"2011","unstructured":"Tanaka S, Ishihara K, Watanabe C, Ohno K, Yamamoto T. Hepatectomy for hepatocellular carcinoma in patients with severe thrombocytopenia. Hepatogastroenterology. 2011;58:1316\u201320.","journal-title":"Hepatogastroenterology"},{"key":"2630_CR33","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2147\/CMAR.S164315","volume":"10","author":"S Wang","year":"2018","unstructured":"Wang S, Ye Q, Tu J, Song Y. The location, histologic type, and stage of lung cancer are associated with bleeding during endobronchial biopsy. Cancer Manag Res. 2018;10:1251\u20137.","journal-title":"Cancer Manag Res"},{"key":"2630_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3892\/mco.2017.1345","volume":"7","author":"L Zhou","year":"2017","unstructured":"Zhou L, Zhang LZ, Wang JY, Li YW, Hu HD, Peng XM, et al. Perioperative safety analysis of transcatheter arterial chemoembolization for hepatocellular carcinoma patients with preprocedural leukopenia or thrombocytopenia. Mol Clin Oncol. 2017;7:435\u201342.","journal-title":"Mol Clin Oncol"},{"key":"2630_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0308-2261(21)00047-3","volume":"7","author":"SJ Slichter","year":"1978","unstructured":"Slichter SJ, Harker LA. Thrombocytopenia: mechanisms and management of defects in platelet production. Clin Haematol. 1978;7:523\u201339.","journal-title":"Clin Haematol"},{"key":"2630_CR36","doi-asserted-by":"crossref","first-page":"376a","DOI":"10.1182\/blood.V94.1.376.413a48d_376_377","volume":"94","author":"SJ Slichter","year":"1999","unstructured":"Slichter SJ, LeBlanc R, Jones MK. Quantitative analysis of bleeding risk in cancer patients (PTS) prophylactically transfused at platelet (PLT) counts (CTS) of, 5000, 10,000, or 20,000. Blood. 1999;94:376a.","journal-title":"Blood"},{"key":"2630_CR37","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1182\/blood.V66.5.1105.1105","volume":"66","author":"SR Hanson","year":"1985","unstructured":"Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood. 1985;66:1105\u20139.","journal-title":"Blood"},{"key":"2630_CR38","first-page":"547","volume":"88","author":"V Chantarangkul","year":"2003","unstructured":"Chantarangkul V, Clerici M, Bressi C, Giesen PL, Tripodi A. Thrombin generation assessed as endogenous thrombin potential in patients with hyper-or hypo-coagulability. Haematologica. 2003;88:547\u201354.","journal-title":"Haematologica"},{"key":"2630_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0895-4356(92)90191-O","volume":"45","author":"MS Green","year":"1992","unstructured":"Green MS, Peled I, Najenson T. Gender differences in platelet count and its association with cigarette smoking in a large cohort in Israel. J Clin Epidemiol. 1992;45:77\u201384.","journal-title":"J Clin Epidemiol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02630-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02630-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02630-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T09:22:06Z","timestamp":1714382526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-024-02630-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,5,18]]}},"alternative-id":["2630"],"URL":"https:\/\/doi.org\/10.1038\/s41416-024-02630-w","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"assertion":[{"value":"23 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KV, EH-P, and HTS declare no personal conflict of interest. Department of Clinical Epidemiology is, however, involved in studies with funding from various companies as research grants to (and administered by) Aarhus University, including this study. Mary Clouser and Hossam Saad are employees of Amgen. Kasper Adelborg is now an employee of Novo Nordisk.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"According to Danish legislation, approval from an ethics committee is not required for registry-based studies. The study was reported to the Danish Data Protection Agency (record no. 1819).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}